Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON50570Completed
Open-label trial in Perinatal infection and Infection, sponsored by Spaarne Gasthuis. Primary endpoints: Short- and long-term prevalence of antimicrobial resistance genes in the gut microbiome and Short- and long-term gut microbiome composition changes. Started Jan 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON50570.